PURPOSE: To evaluate the time course of late rectal mucosal changes after prostate cancer radiotherapy (RT). PATIENTS AND METHODS: A rectosigmoidoscopy was performed at 12, 24, and 65 months after RT in 20 patients. Rectal mucosal changes (telangiectasia, congested mucosa, ulceration, stricture, and necrosis) were scored and documented according to the Vienna Rectoscopy Score (VRS, score 0-3). RESULTS: VRS of 0 and 3, were found in 20% of patients (n = 4) and 5% of patients (n = 1), respectively at all time points. A shift of the VRS from 2 to 1 was found with incidence rates of 60% at 12 months and 20% at 65 months, which is equivalent to an improvement rate of 67%. Laser coagulation was required in 3 patients (15%) with rectal bleeding due to telangiectasia grade ≥2. CONCLUSION: Late rectal mucosal changes are frequent after pelvic RT. Generally only the incidence rates corresponding to the initial diagnosis of the complications, independent of subsequent recovery, are reported. The results reported in the present study show that complications often improve over time. Hence, the usual reports of complication rates overestimate the proportion of patients presenting with side effects of certain grades.
PURPOSE: To evaluate the time course of late rectal mucosal changes after prostate cancer radiotherapy (RT). PATIENTS AND METHODS: A rectosigmoidoscopy was performed at 12, 24, and 65 months after RT in 20 patients. Rectal mucosal changes (telangiectasia, congested mucosa, ulceration, stricture, and necrosis) were scored and documented according to the Vienna Rectoscopy Score (VRS, score 0-3). RESULTS: VRS of 0 and 3, were found in 20% of patients (n = 4) and 5% of patients (n = 1), respectively at all time points. A shift of the VRS from 2 to 1 was found with incidence rates of 60% at 12 months and 20% at 65 months, which is equivalent to an improvement rate of 67%. Laser coagulation was required in 3 patients (15%) with rectal bleeding due to telangiectasia grade ≥2. CONCLUSION: Late rectal mucosal changes are frequent after pelvic RT. Generally only the incidence rates corresponding to the initial diagnosis of the complications, independent of subsequent recovery, are reported. The results reported in the present study show that complications often improve over time. Hence, the usual reports of complication rates overestimate the proportion of patients presenting with side effects of certain grades.
Authors: Roberto Zinicola; Matthew D Rutter; Giuliano Falasco; Jim C Brooker; Vincenzo Cennamo; Sandro Contini; Brian P Saunders Journal: Int J Colorectal Dis Date: 2003-04-04 Impact factor: 2.571
Authors: Gregor Goldner; Birgit Tomicek; Gerd Becker; Hans Geinitz; Stefan Wachter; Frank Zimmermann; Natascha Wachter-Gerstner; Jochen Reibenwein; Stefan Glocker; Michael Bamberg; Horst Feldmann; Regina Pötzi; Michael Molls; Richard Pötter Journal: Int J Radiat Oncol Biol Phys Date: 2007-01-01 Impact factor: 7.038
Authors: Amit K Garg; Wei-Yuan Mai; John E McGary; Walter H Grant; E Brian Butler; Bin S Teh Journal: Int J Radiat Oncol Biol Phys Date: 2006-12-01 Impact factor: 7.038
Authors: Tereza Kertesz; Markus K A Herrmann; Antonia Zapf; Hans Christiansen; Robert M Hermann; Olivier Pradier; Heinz Schmidberger; Clemens F Hess; Andrea Hille Journal: Strahlenther Onkol Date: 2009-09-12 Impact factor: 3.621
Authors: Peter C O'Brien; Christopher S Hamilton; James W Denham; Ralph Gourlay; C Ian V Franklin Journal: Int J Radiat Oncol Biol Phys Date: 2004-01-01 Impact factor: 7.038
Authors: A-C Müller; J Lütjens; M Alber; F Eckert; M Bamberg; D Schilling; C Belka; U Ganswindt Journal: Strahlenther Onkol Date: 2012-10-11 Impact factor: 3.621
Authors: Robin Krol; Robert Jan Smeenk; Emile N J T van Lin; Eric E K Yeoh; Wim P M Hopman Journal: Int J Colorectal Dis Date: 2013-10-23 Impact factor: 2.571
Authors: Anna C Nuijens; Arlene L Oei; Anne Bouhuijs; Nicolaas A P Franken; Coen R N Rasch; Lukas J A Stalpers Journal: Cancers (Basel) Date: 2022-03-25 Impact factor: 6.639